Business Context and Reporting Period
Company: BioRestorative Therapies, Inc. (BRTX)
Filing Type: Form 8-K (Current Report)
Date of Report: September 2, 2026
Event: Announcement of a 1-for-20 reverse stock split of common stock.
Key Financial Metrics
This filing is a corporate action report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
- Reverse Stock Split: A 1-for-20 reverse stock split was approved by the Board of Directors on August 27, 2026.
- Effective Date: The split becomes effective at 4:30 p.m. Eastern Time on September 7, 2026.
- Share Count Reduction: Outstanding shares will decrease from 27,622,556 to approximately 1,381,128.
- Authorized Shares: Authorized common shares will decrease from 1,500,000,000 to 75,000,000.
- Fractional Shares: No fractional shares will be issued; holders entitled to fractions will receive one whole share rounded up.
- Trading Adjustments: Stock will begin trading on a reverse split-adjusted basis on September 8, 2026, under symbol "BRTX" with a new CUSIP (090655705).
- Equity Awards: Proportionate adjustments will be made to outstanding options, warrants, and the 2021 Stock Incentive Plan.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the description of the Certificate of Change is qualified by reference to the full text of the document. The primary purpose is to disclose the structural change to the company's capitalization.
Investor Verification Checklist
- Verify the exact number of shares held post-split, noting the rounding up of fractional shares.
- Confirm the new CUSIP number (090655705) with your broker for trading on September 8, 2026.
- Review the treatment of any outstanding options or warrants to ensure exercise prices and share counts are adjusted correctly.
- Contact brokers regarding the specific procedures for shares held in street name, as they may differ from record holders.